KiOmed Pharma SA
30.2 FTEKiOmed Pharma reported total assets of €19.7m at the end of the 2025 financial year (annual accounts filed with the NBB on 02 Jun 2026), with 30.2 full-time equivalents.
The score of KiOmed Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -2 % Total assets +29 % Headcount (avg FTE) +54 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
KiOmed Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 02 Jun 2026
- Year ended 31 Dec 2024filed on 20 Jun 2025
- Year ended 31 Dec 2023filed on 05 Jun 2024
- Year ended 31 Dec 2022filed on 09 Jun 2023
- Year ended 31 Dec 2021filed on 22 Jun 2022
KiOmed Pharma's financial analysis
- Solvency45.9%sector median: 57.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of KiOmed Pharma
KiOmed Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0846.318.862
- VAT number
- BE0846318862
- Peppol
- Registered · 0208:0846318862 · as of 12 Nov 2026
- Legal form
- SA
- Incorporated
- 04 Jun 2012
- Registered office
- 4041 Herstal
- Size
- Small · 30.2 FTE
- Latest accounts
- 2025 · filed on 02 Jun 2026
- Activity
- Research and experimental development on other natural sciences and engineering (NACE 72109)
KiOmed Pharma (SA) has been based in Herstal since 2012, active in: research and experimental development on other natural sciences and engineering. For 2025, it reports a net profit of €2.19m and equity of €9.02m; its revenue is not published. With 30.2 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 45.9%, below the median of its sector (57.9%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to KiOmed Pharma
Companies in the same business, of comparable size and area, outside its group.
- invoX Belgium Manufacture of pharmaceutical preparations Diepenbeek · balance sheet €29.2m
- Belgian Volition Research and experimental development on natural sciences and engineering Gembloux · balance sheet €42.6m
- Biocartis Research and experimental development on natural sciences and engineering Mechelen · balance sheet €61.8m
- Axithra Research and experimental development on natural sciences and engineering Ghent · balance sheet €8.60m
- ATB Therapeutics Manufacture of basic pharmaceutical products Marche-en-Famenne · balance sheet €10.6m
- Istar Medical Manufacture of medical and dental instruments and supplies Wavre · balance sheet €15.6m
- Synergia Medical Computer programming activities Mont-Saint-Guibert · balance sheet €6.13m
- Fresenius Medical Care Belgium Wholesale of pharmaceutical and medical goods Willebroek · balance sheet €21.9m
Frequently asked questions about KiOmed Pharma
What is the revenue of KiOmed Pharma?
KiOmed Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of KiOmed Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0846318862 for KiOmed Pharma, if the company is VAT-registered. Its company number (CBE) is 0846.318.862.
Where is the registered office of KiOmed Pharma?
According to the CBE register, the registered office of KiOmed Pharma is in 4041 Herstal.
What is the equity of KiOmed Pharma?
At the close of the 2025 financial year, the equity of KiOmed Pharma amounts to 9,021,523 €, a solvency of 45.9% of total assets.
How many people work at KiOmed Pharma?
30.2 full-time equivalents on average according to the 2025 social balance sheet.
Who manages KiOmed Pharma?
The register lists 15 active mandates at KiOmed Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of KiOmed Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →